在质母细胞瘤中存活率和远程复发的预测
Raquel Gutiérrez-González1,2, Zulema Herrero3, Enrique Rodriguez-Rubio4
1Department of Neurosurgery, Puerta de Hierro University Hospital, Madrid, Spain. rgutierrezgonzalez@yahoo.es.
Neurologia i neurochirurgia polska
|March 9, 2026
概括
在低瘤负担的质母细胞瘤患者中,远程复发与更好的生存结果有关. 表皮生长因子受体 (EGFR) 放大和低Ki-67是远期复发的关键预测因素.
科学领域:
- 神经瘤学神经瘤学
- 癌症复发模式 癌症复发模式
- 质母细胞瘤研究研究
背景情况:
- 质母细胞瘤是一种具有高复发率的侵袭性脑瘤.
- 远程复发对存活率的影响仍在争论中.
- 这项研究侧重于新的质母细胞瘤,其残留瘤体积低 (<5厘米).
研究的目的:
- 为了研究远程复发模式对质母细胞瘤患者的生存的影响.
- 在这个患者队列中确定预测远期复发的因素.
- 为了告知临床试验设计和患者管理策略.
主要方法:
- 回顾性单中心队列研究 (2017-2023年).
- 纳入标准:18岁以上的患有新质母细胞瘤和RTV<5cc的患者.
- 卡普兰-梅尔分析时间到事件和对风险因素的后勤回归.
主要成果:
- 分析了102名患者;中位生存期为12.9个月.
- 远程复发与更长的无进展生存时间 (11.9 vs 6.1 个月) 和整体生存时间 (21.5 vs 12.7 个月) 相相关.
- 皮表皮肤生长因子受体 (EGFR) 放大和Ki-67<30%独立预测远期复发.
结论:
- 低负荷质母细胞瘤的远程复发与改善的生存率有关.
- EGFR放大和低Ki-67是远程进展的显著预测因素.
- 分子造型和复发模式分层对于质母细胞瘤管理和临床试验至关重要.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


